April 25, 2019
FDA issues draft guidance on initiating voluntary recalls
Editor's Note
The Food and Drug Administration (FDA) on April 23 issued a new draft guidance to help manufacturers avoid delays in preparing, planning, and executing voluntary recalls.
The guidance includes recommendations in three areas:
- proper training of personnel
- thorough and organized record keeping
- written recall initiation procedures.
The guidance is the latest step in the agency’s commitment to working with companies to quickly act to protect consumers from potentially dangerous products, the FDA says.
Free Daily News
- Hospital margins improve as outpatient revenue accelerates, but costs loom
- Breast cancer surgery delays tied to higher upstaging, faster tumor growth
- Exercise programs ease stress and burnout for nurses, review finds
- WHO and robotic surgery society partner to expand global access to telesurgery
- Health systems lean toward established partners for AI adoption
- Immigration raids are driving patients back to telehealth and ERs
- Study: Global access to surgery deemed a crisis, leaves 160 million without care
- Large-scale studies link preoperative cognition to delirium risk, reveal its deadly toll after surgery
- Socioeconomic deprivation linked to lower fitness before surgery, UK study finds
- Perioperative medication decisions need individualized risk-benefit approach
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement